(Pharmamar) PharmaMar (MSE:PHM) has announced today a licensing agreement with Eczasibasi Group to commercialize the marine-derived anticancer drug Aplidin® (plitidepsin) in Turkey.
############
Story Source: Materials provided by Scienmag
PharmaMar and Eczasibasi sign a licensing agreement for Aplidin® in Turkey
Please login to join discussion
POPULAR NEWS
-
Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission
-
Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps
-
ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy
-
New Study Suggests ALS and MS May Stem from Common Environmental Factor